0
Article Tier 2 Human Health Effects Sign in to save

CD44 as a Central Integrator of Inflammation and Fibrosis: From Molecular Signaling to Environmental Modulation

International Journal of Molecular Sciences 2025 5 citations

AI summary Read the abstract

This review examines CD44, a protein on cell surfaces that acts as a key driver of inflammation and scarring (fibrosis) in organs like the lungs, skin, heart, and liver. The paper also discusses how environmental pollutants, including microplastics, heavy metals, and endocrine disruptors, can activate the CD44 pathway and trigger chronic inflammation and tissue damage. This research helps explain one of the molecular mechanisms by which microplastic exposure could lead to long-term organ damage.

CD44, a multi-isoform adhesion receptor for hyaluronic acid (HA), plays a crucial role in regulating cell interactions with the extracellular matrix, cell migration, differentiation, and survival in both physiological and pathological contexts. Accumulating experimental evidence suggests that CD44 is not merely a passive marker of mesenchymal cell activation but rather an active signaling hub driving fibrosis in many organs, including the lung, skin, heart, and liver. Its involvement in fibroblast differentiation into myofibroblasts, as well as induction of the invasive phenotype of these cells, shows striking analogies to the mechanisms of epithelial-to-mesenchymal transition (EMT) known from cancer progression. In this paper, we discuss both the molecular mechanisms of CD44-dependent signaling (including through EGFR, MAPK/ERK, CaMKII, lipid rafts, and Smad) and the influence of its modulation (knockout, antibodies, blockade of HA synthesis) on the course of fibrosis in in vitro and in vivo models. In addition, we present the influence of environmental pollutants-such as heavy metals, particulate matter, endocrine disruptors, and microplastics-on the activation of the HA-CD44 axis in connective tissue, with particular emphasis on their role in the induction of chronic inflammation, EMT, and extracellular matrix deposition. The collected evidence suggests that CD44 serves as a central integrator of inflammatory and fibrogenic signals, and its pharmacological modulation may represent a novel therapeutic strategy for treating fibrotic diseases and chronic inflammatory conditions.

More Papers Like This

Article Tier 2

A particle of concern: explored and proposed underlying mechanisms of microplastic-induced lung damage and pulmonary fibrosis

AI summary Read the abstract

This paper explores how inhaled microplastics may cause lung damage and scarring (pulmonary fibrosis) through several biological pathways. The research identifies signaling pathways that could be targeted for future treatments to reduce microplastic-induced lung damage. This is relevant to human health because people regularly breathe in airborne microplastic particles.

Article Tier 2

Microplastics as a Cross-Disease Driving Risk Factor in Lung Pathogenesis: An Integrative Study Combining In Silico Analysis and Experimental Validation Using Polystyrene Nanoplastics

AI summary Read the abstract

Scientists found that tiny plastic particles (nanoplastics) may contribute to serious lung diseases like COPD, pulmonary fibrosis, and lung cancer by switching on a gene called CDK1, which causes lung cells to scar and malfunction. In lab tests on human lung cells, exposure to these plastic particles triggered fibrosis (tissue scarring), and blocking CDK1 reduced this damage—suggesting this gene could be a target for future treatments. This research adds to growing evidence that the microplastics we breathe in from air pollution may have real consequences for lung health, not just being a passive pres

Article Tier 2

Exposure to environmental xenobiotics and lung tissue function: A comprehensive review on biological mechanisms and pathways

AI summary Read the abstract

This comprehensive review examines how environmental pollutants including microplastics, heavy metals, and volatile organic compounds damage lung tissue through mechanisms like oxidative stress, inflammation, and disruption of cellular barriers. The study suggests these pollutants contribute to chronic respiratory diseases and highlights how they can also cause epigenetic changes that may affect future generations.

Article Tier 2

Mechanism of Nano‐Microplastics Exposure‐Induced Myocardial Fibrosis: DKK3‐Mediated Mitophagy Dysfunction and Pyroptosis

AI summary Read the abstract

Researchers investigated how nano-microplastic exposure leads to heart tissue scarring in mice and identified a specific molecular pathway involved. They found that the plastic particles suppressed a protein called DKK3, which disrupted the cell's ability to recycle damaged mitochondria, triggering an inflammatory cell death process that promotes fibrosis. The study reveals a potential mechanism by which long-term microplastic exposure could contribute to cardiac damage.

Article Tier 2

The histopathological and functional consequences of microplastic exposure

AI summary Read the abstract

This review summarizes existing research on how microplastics cause physical damage to organs across multiple body systems, including the heart, brain, lungs, gut, and reproductive organs. The most common pattern is that microplastics trigger inflammation, which leads to scarring (fibrosis) and loss of organ function. These findings suggest that microplastic exposure could contribute to a range of health problems throughout the body.

Research digests by email

When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.

Email me about

Share this paper